Catherine Moukheibir - Mar 15, 2023 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Stock symbol
IRWD
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
4
Date filed
3/17/2023, 04:05 PM
Previous filing
Jun 3, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +1.68K +1.69% $0.00 101K Mar 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023.